Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line
NCT05372198
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Neoplasms
Interventions
DRUG:
Chohort 1: Surufatinib
DRUG:
Chohort 2: Immunotherapy
DRUG:
Chohort 2: Surufatinib
Sponsor
Hubei Cancer Hospital